proteas
pro
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
vital
sarscov
replic
promis
drug
target
structur
base
virtual
screen
chemic
compound
perform
use
comput
tool
autodock
wisdom
product
environ
top
rank
compound
free
bind
energi
rang
kcal
mol
select
check
hydrogen
bond
interact
amino
acid
residu
activ
site
pro
fiftythre
compound
main
group
test
vitro
assay
inhibit
pro
express
escherichia
coli
seven
compound
select
ic
rang
lm
two
strong
pro
inhibitor
identifi
competit
inhibitor
pro
k
valu
lm
hydrophob
hydrogen
bond
interact
compound
amino
acid
residu
activ
site
pro
also
identifi
elsevi
ltd
right
reserv
sever
acut
respiratori
syndrom
sar
sever
febril
respiratori
ill
caus
sarsassoci
coronaviru
sarscov
global
outbreak
sar
march
juli
caus
probabl
confirm
case
death
mortal
rate
high
estim
world
health
organ
possibl
reemerg
sar
seriou
threat
sinc
effici
therapi
vaccin
current
avail
sarscov
genom
contain
function
open
read
frame
orf
two
larg
termin
orf
design
encod
two
overlap
polyprotein
respect
design
cleav
extens
produc
protein
necessari
viral
rna
synthesi
genom
replic
sarscov
proteas
pro
play
major
role
process
viral
polyprotein
control
activ
replicas
complex
enzymat
activ
pro
essenti
viral
life
cycl
therefor
repres
attract
target
develop
antivir
drug
direct
sarscov
coronaviru
infect
past
decad
highthroughput
virtual
screen
vs
emerg
especi
structur
base
virtual
screen
sbv
reliabl
costeffect
timesav
techniqu
discoveri
lead
compound
altern
highthroughput
screen
vs
appli
discoveri
new
enzym
inhibitor
involv
dock
comput
fit
structur
compound
activ
site
enzym
score
rank
compound
studi
identifi
novel
pro
inhibitor
among
compound
sbv
dock
calcul
wisdom
wide
silico
dock
malaria
product
environ
wpe
addit
inhibit
activ
enzym
kinet
character
vitro
enzym
assay
coordin
xray
crystal
structur
pro
pdb
access
code
obtain
protein
data
bank
pdb
http
wwwpdborg
use
receptor
model
sbv
dock
simul
remov
water
molecul
polar
hydrogen
h
atom
ad
macromolecul
histidin
residu
made
neutral
kollman
charg
assign
atom
dock
librari
pro
compris
see
front
matter
virtual
screen
identif
novel
sever
acut
respiratori
syndrom
proteas
inhibitor
vitro
confirm
b
r
c
proteas
pro
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
vital
sarscov
replic
promis
drug
target
structur
base
virtual
screen
chemic
compound
perform
use
comput
tool
autodock
wisdom
product
environ
top
rank
compound
free
bind
energi
rang
kcal
mol
select
check
hydrogen
bond
interact
amino
acid
residu
activ
site
pro
fiftythre
compound
main
group
test
vitro
assay
inhibit
pro
express
escherichia
coli
seven
compound
select
ic
rang
lm
two
strong
pro
inhibitor
identifi
competit
inhibitor
pro
k
valu
lm
hydrophob
hydrogen
bond
interact
compound
amino
acid
residu
activ
site
pro
also
identifi
elsevi
ltd
right
reserv
sever
acut
respiratori
syndrom
sar
sever
febril
respiratori
ill
caus
sarsassoci
coronaviru
sarscov
global
outbreak
sar
march
juli
caus
probabl
confirm
case
death
mortal
rate
high
estim
world
health
organ
possibl
reemerg
sar
seriou
threat
sinc
effici
therapi
vaccin
current
avail
sarscov
genom
contain
function
open
read
frame
orf
two
larg
termin
orf
design
encod
two
overlap
polyprotein
respect
design
cleav
extens
produc
protein
necessari
viral
rna
synthesi
genom
replic
sarscov
proteas
pro
play
major
role
process
viral
polyprotein
control
activ
replicas
complex
enzymat
activ
pro
essenti
viral
life
cycl
therefor
repres
attract
target
develop
antivir
drug
direct
sarscov
coronaviru
infect
past
decad
highthroughput
virtual
screen
vs
emerg
especi
structur
base
virtual
screen
sbv
reliabl
costeffect
timesav
techniqu
discoveri
lead
compound
altern
highthroughput
screen
vs
appli
discoveri
new
enzym
inhibitor
involv
dock
comput
fit
structur
compound
activ
site
enzym
score
rank
compound
studi
identifi
novel
pro
inhibitor
among
compound
sbv
dock
calcul
wisdom
wide
silico
dock
malaria
product
environ
wpe
addit
inhibit
activ
enzym
kinet
character
vitro
enzym
assay
coordin
xray
crystal
structur
pro
pdb
access
code
obtain
protein
data
bank
pdb
http
wwwpdborg
use
receptor
model
sbv
dock
simul
remov
water
molecul
polar
hydrogen
h
atom
ad
macromolecul
histidin
residu
made
neutral
kollman
charg
assign
atom
dock
librari
pro
compris
see
front
matter
elsevi
ltd
right
reserv
wwwchembridgecom
compound
filter
remov
unsuit
compon
would
reach
pass
clinic
trial
due
undesir
toxic
properti
three
dimension
atom
coordin
compound
includ
dock
librari
gener
corina
program
molecular
network
gmbh
erlangen
germani
autodock
version
use
comput
molecular
dock
simul
flexibl
small
molecul
rigid
protein
ligand
rigid
protein
larg
scale
comput
conduct
compound
use
kisti
grid
infrastructur
first
postdock
filter
strategi
base
free
bind
energi
lowest
energi
conform
top
rank
compound
free
bind
energi
rang
kcal
mol
select
narrow
drug
candid
select
chimera
softwar
program
univers
california
san
francisco
use
identifi
potenti
hbond
residu
activ
site
pocket
pro
select
compound
analyz
hydrophob
hbond
interact
use
ligplot
program
among
compound
compound
top
score
compound
exhibit
potenti
hydrogen
bond
hbond
interact
compound
top
score
compound
show
weak
hbond
interact
amino
acid
residu
activ
site
pocket
pro
accord
free
bind
energi
hbond
interact
key
residu
compound
select
classifi
group
librari
mc
chemaxon
san
francisco
ca
usa
fiftythre
compound
select
main
cluster
vitro
inhibitori
activ
pro
compound
provid
vendor
pure
use
without
treatment
gene
encod
pro
sarscov
polyprotein
amino
acid
residu
genbank
access
construct
custom
gene
synthesi
servic
genscript
piscataway
nj
usa
pro
enzym
express
e
coli
purifi
use
nisepharos
resin
ge
healthcar
buckinghamshir
uk
k
valu
pro
calcul
doubl
reciproc
lineweaverburk
plot
fluorogen
peptid
dabcylktsavlqsgfrkmeedan
use
spectramax
gemini
xp
apparatu
molecular
devic
eugen
usa
excit
fluoresc
emiss
wavelength
nm
respect
compound
vs
test
duplic
concentr
lm
abil
inhibit
pro
activ
seven
compound
show
optim
inhibit
pro
lm
tabl
chemic
structur
compound
depict
figur
physicochem
chemic
name
compound
suppli
supplementari
data
seven
compound
display
pro
inhibitori
activ
ic
valu
rang
lm
tabl
compound
consid
new
inhibitor
scaffold
develop
structur
activ
relationship
de
novo
design
studi
compound
similar
structur
display
inhibit
activ
lm
subject
kinet
character
elucid
inhibitori
mechan
compound
inhibit
kinet
experi
perform
differ
constant
inhibitor
con
centrat
lm
differ
substrat
concentr
analysi
mode
inhibit
compound
lineweaverburk
dixon
plot
use
k
valu
calcul
dixon
plot
use
sigmaplot
program
spss
san
diego
ca
usa
compound
competit
inhibitor
inhibit
pro
compound
illustr
figur
lineweaverburk
plot
versu
result
famili
straight
line
yaxi
intercept
reflect
competit
inhibit
toward
pro
fig
activ
suggest
compound
potent
impair
catalyt
activ
pro
bind
enzym
catalyt
site
k
valu
compound
determin
lm
respect
common
xaxi
intercept
line
correspond
dixon
plot
fig
compound
analyz
molecular
dock
potent
binder
activ
site
pocket
pro
fig
predict
free
bind
energi
compound
pro
shown
tabl
figur
distanc
anoth
one
n
atom
main
chain
distanc
view
hbond
compound
amino
acid
residu
activ
site
pro
reveal
compound
bound
site
substrat
bind
pocket
sarscov
hbond
sarscov
pro
confer
absolut
specif
substrat
residu
nitrophenyl
group
compound
like
crucial
pro
inhibit
activ
given
hbond
format
well
hydrophob
interact
henc
one
catalyt
dyad
residu
pro
vital
bind
compound
pro
summari
vs
compound
done
identifi
novel
pro
inhibitor
fiftythre
compound
test
inhibitori
activ
toward
pro
express
e
coli
ic
seven
especi
potent
compound
rang
lm
two
compound
competit
inhibitor
pro
k
valu
lm
detail
dock
simul
bind
mode
analys
show
inhibitor
could
stabil
format
hbond
catalyt
residu
establish
hydrophob
contact
opposit
region
activ
site
detail
inhibit
kinet
molecular
model
studi
underway
elucid
inhibitori
mechan
compound
